Bio-Path Inc. (BPTH)
Bio-Path Statistics
Share Statistics
Bio-Path has 8.31M shares outstanding. The number of shares has increased by 299.38% in one year.
| Shares Outstanding | 8.31M |
| Shares Change (YoY) | 299.38% |
| Shares Change (QoQ) | 92.9% |
| Owned by Institutions (%) | 5.94% |
| Shares Floating | 6.37M |
| Failed to Deliver (FTD) Shares | 2.28K |
| FTD / Avg. Volume | 0.55% |
Short Selling Information
The latest short interest is 77.76K, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 77.76K |
| Short % of Shares Out | 1.35% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 0.03 |
Valuation Ratios
The PE ratio is -0.28 and the forward PE ratio is -0.54. Bio-Path's PEG ratio is 0.
| PE Ratio | -0.28 |
| Forward PE | -0.54 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 18.09 |
| P/FCF Ratio | -0.26 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bio-Path.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.15 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | - |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-989.4K |
| Employee Count | 10 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -96.28% in the last 52 weeks. The beta is 0.02, so Bio-Path's price volatility has been higher than the market average.
| Beta | 0.02 |
| 52-Week Price Change | -96.28% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 32.83 |
| Average Volume (20 Days) | 417.77K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -9.89M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -4.12 |
Balance Sheet
The company has 1.17M in cash and 83K in debt, giving a net cash position of 1.09M.
| Cash & Cash Equivalents | 1.17M |
| Total Debt | 83K |
| Net Cash | 1.09M |
| Retained Earnings | -117.5M |
| Total Assets | 2.96M |
| Working Capital | -476K |
Cash Flow
In the last 12 months, operating cash flow was -10.57M and capital expenditures 0, giving a free cash flow of -10.57M.
| Operating Cash Flow | -10.57M |
| Capital Expenditures | 0 |
| Free Cash Flow | -10.57M |
| FCF Per Share | -4.4 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BPTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BPTH is $20, which is 12400% higher than the current price. The consensus rating is "Buy".
| Price Target | $20 |
| Price Target Difference | 12400% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 23, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Feb 23, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -67.89 |
| Piotroski F-Score | 2 |